Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationStem CellsTransplantation ConditioningLiver TransplantationBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsKidney TransplantationTreatment OutcomeHematopoietic Stem Cell MobilizationCombined Modality TherapyGraft SurvivalCyclophosphamideHematopoietic Stem CellsMultiple MyelomaImmunosuppressive AgentsGraft vs Host DiseaseAntigens, CD34Graft RejectionEmbryonic Stem CellsHeart TransplantationEtoposideAdult Stem CellsGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationRetrospective StudiesHematologic NeoplasmsPluripotent Stem CellsTime FactorsTransplantation ChimeraCord Blood Stem Cell TransplantationStem Cell NicheCell DifferentiationTissue DonorsNeural Stem CellsCell TransplantationInduced Pluripotent Stem CellsMyeloablative AgonistsMesenchymal Stromal CellsProspective StudiesRecurrenceBusulfanMultipotent Stem CellsDisease-Free SurvivalMelphalanWhole-Body IrradiationHistocompatibility TestingSurvival AnalysisSurvival RateChemotherapy, AdjuvantStem Cell FactorRemission InductionHistocompatibilityCell LineageLeukemiaAntineoplastic AgentsCells, CulturedGraft vs Leukemia EffectSalvage TherapyFetal Stem CellsBone Marrow CellsLeukemia, Myeloid, AcuteVidarabineFollow-Up StudiesPrognosisTransplantation ImmunologyCell ProliferationHematopoiesisStem Cell ResearchLymphoma, Non-HodgkinFlow CytometryLung TransplantationHematologic DiseasesHepatic Veno-Occlusive DiseaseChimerismCytarabineGraft vs Tumor EffectMyelodysplastic SyndromesTransplantation, IsogeneicOrgan TransplantationDoxorubicinHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaRegenerationPlant StemsHLA AntigensMice, Inbred C57BLCell SeparationLymphocyte TransfusionSiblingsNeoplastic Stem CellsCell Culture TechniquesTransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionT-LymphocytesBone Marrow